Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Vicky Torrano"'
Autor:
Tamara Tripic, Malcolm K. Brenner, Cecilia Barese, Daniel Y. Lee, Hao Liu, Adrian P. Gee, Helen E. Heslop, Vicky Torrano, Catherine M. Bollard, Stephen Gottschalk, Olga Dakhova, Owen A. O'Connor, Youli Zu, Cliona M. Rooney, Gianpietro Dotti, Conrad Russell Y. Cruz, Andrea N. Marcogliese, Meng-Fen Wu, George Carrum, Carlos A. Ramos
Publikováno v:
Journal of Clinical Oncology. 36:1128-1139
Purpose Transforming growth factor-β (TGF-β) production in the tumor microenvironment is a potent and ubiquitous tumor immune evasion mechanism that inhibits the expansion and function of tumor-directed responses; therefore, we conducted a clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f11e85c1eaf91c3c86a0847ea59ba7
https://doi.org/10.1200/jco.2017.74.3179
https://doi.org/10.1200/jco.2017.74.3179
Autor:
Enli Liu, Zhuyong Mei, Hao Liu, Rammurti T. Kamble, Bambi Grilley, Barbara Savoldo, Helen E. Heslop, Malcolm K. Brenner, Brandon Ballard, Huimin Zhang, Gianpietro Dotti, Olga Dakhova, Adrian P. Gee, George Carrum, Meng Fen Wu, Cliona M. Rooney, Vicky Torrano, Carlos A. Ramos
Publikováno v:
Journal of Clinical Investigation. 126:2588-2596
BACKGROUND. Treatment of B cell malignancies with adoptive transfer of T cells with a CD19-specific chimeric antigen receptor (CAR) shows remarkable clinical efficacy. However, long-term persistence of T cells targeting CD19, a pan–B cell marker, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f28b9609e4bcf365b4bc2148f51c910
https://doi.org/10.1172/jci86000
https://doi.org/10.1172/jci86000
Autor:
Andrea M. Sheehan, Youli Zu, Elizabeth J. Shpall, Cliona M. Rooney, Barbara Pro, Stephanie Ku, Daniel Lee, George Carrum, Oumar Diouf, Malcolm K. Brenner, Meng Fen Wu, Hao Liu, Catherine M. Bollard, Adrian P. Gee, Luis Fayad, Stephen Gottschalk, Yasmin Hazrat, Carlos A. Ramos, Helen E. Heslop, Vicky Torrano
Publikováno v:
Journal of Clinical Oncology. 32:798-808
Purpose Tumor cells from approximately 40% of patients with Hodgkin or non-Hodgkin lymphoma express the type II latency Epstein-Barr virus (EBV) antigens latent membrane protein 1 (LMP1) and LMP2, which represent attractive targets for immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5ea9ca917694cde007d16e505becd7b
https://doi.org/10.1200/jco.2013.51.5304
https://doi.org/10.1200/jco.2013.51.5304
Autor:
G. Dotti, Mrinalini Bilgi, Cliona M. Rooney, Olga Dakhova, Zhuyong Mei, Helen E. Heslop, Carlos A. Ramos, Barbara Savoldo, Meng-Fen Wu, Adrian P. Gee, Bambi Grilley, Malcolm K. Brenner, Claudia Gerken, Vicky Torrano
Publikováno v:
Hematological Oncology. 37:168-168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c13a260145e86b69461a9f945557cff6
https://doi.org/10.1002/hon.125_2629
https://doi.org/10.1002/hon.125_2629
Autor:
Cliona M. Rooney, Conrad Russell Y. Cruz, Patrick J. Hanley, Helen E. Heslop, Chrystal U. Louis, James A. Arce, Gianpietro Dotti, Yu Feng Lin, Malcolm K. Brenner, Barbara Savoldo, Hao Liu, Ann M. Leen, Catherine M. Bollard, Adrian P. Gee, Stephen Gottschalk, Vicky Torrano
Publikováno v:
Cytotherapy. 12:743-749
Background aims The Food and Drug Administration (FDA) currently recommends at least 4h of recipient monitoring after T cell infusions to detect early infusion reactions. Recent catastrophic reactions to ‘first-in-man' biologic agents have emphasiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6782bf1d017ca99af29e91786d5fb422
https://doi.org/10.3109/14653241003709686
https://doi.org/10.3109/14653241003709686
Autor:
Carlos A. Ramos, Adrian P. Gee, Minthran Ngo, Vicky Torrano, Lisa Rollins, Cliona M. Rooney, Catherine M. Bollard, Stephen Gottschalk, Jun Ando, Oumar Diouf, Natalia Lapteva, Helen E. Heslop, Ann M. Leen, Juan F. Vera, Serena K. Perna
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a005eb2174001348c8efdcb8b9b0be6c
Autor:
Catherine M. Bollard, Karen L. Hodgkin, Carlos A. Ramos, Helen E. Heslop, Shannon Inman, Sandhya Sharma, Birju Mehta, Fnu Spoorthi, Serena K. Perna, Vicky Torrano, Kurt C. Gunter, Rayne H. Rouce, Malcolm K. Brenner, Adrian P. Gee, Cliona M. Rooney, Natalia Lapteva, Benjamin Shin
Publikováno v:
Blood. 128:2990-2990
Up to 30 % of Hodgkin and non-Hodgkin lymphomas carry the Epstein Barr virus (EBV) genome and express the viral latency type 2 proteins EBNA-1, LMP-1, LMP-2 and BARF-1 in a pattern termed Type 2 latency. We have previously shown that Epstein-Barr vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cb24f9e1122cd70feec69742f2a3db3
https://doi.org/10.1182/blood.v128.22.2990.2990
https://doi.org/10.1182/blood.v128.22.2990.2990
Autor:
Vicky Torrano, Rayne H. Rouce, M.K. Brenner, Adrian P. Gee, Serena K. Perna, Sandhya Sharma, C.M. Rooney, Natalia Lapteva, Helen E. Heslop, Carlos A. Ramos, Catherine M. Bollard
Publikováno v:
Cytotherapy. 18:S21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae72e3ddc11d7f54948c3d98a29bcac7
https://doi.org/10.1016/j.jcyt.2016.03.058
https://doi.org/10.1016/j.jcyt.2016.03.058
Autor:
Natalia Lapteva, Minhtran C. Ngo, Cliona M. Rooney, Catherine M. Bollard, Rayne H. Rouce, Serena K. Perna, Carlos A. Ramos, Ann M. Leen, Sandhya Sharma, Adrian P. Gee, Birju Mehta, Helen E. Heslop, Vicky Torrano
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Up to ~40 % of Hodgkin and non-Hodgkin lymphomas carry the Epstein-Barr virus (EBV) genome and express type 2 viral latency proteins (T2LPs) EBNA-1, LMP-1, LMP-2 and BARF-1. EBV specific T cells (EBVSTs) can be generated from the bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27367a5063d170d3f93a92af91e91389
http://europepmc.org/articles/PMC4646123
http://europepmc.org/articles/PMC4646123
Autor:
Sandhya Sharma, Serena K. Perna, Vicky Torrano, Helen E. Heslop, Cliona M. Rooney, Rayne H. Rouce, Natalia Lapteva, Minhtran C. Ngo, Catherine M. Bollard, Carlos A. Ramos
Publikováno v:
Molecular Therapy. 23:S288
Up to 30% of Hodgkin and non-Hodgkin lymphomas carry the Epstein-Barr virus (EBV) genome and express the viral latency proteins EBNA1, LMP1, LMP2 and BARF1; a type 2 latency pattern of EBV gene expression. We previously reported that EBV-specific T-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b12d1087ce226c8441a66b4bef4747
https://doi.org/10.1016/s1525-0016(16)34331-3
https://doi.org/10.1016/s1525-0016(16)34331-3